PTC Therapeutics Inc (PTCT)
25.97
+0.65
(+2.57%)
USD |
NASDAQ |
Apr 22, 16:00
25.97
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Cash from Operations (TTM): -158.42M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -158.42M |
September 30, 2023 | -224.09M |
June 30, 2023 | -247.62M |
March 31, 2023 | -288.74M |
December 31, 2022 | -356.65M |
September 30, 2022 | -259.53M |
June 30, 2022 | -272.68M |
March 31, 2022 | -248.58M |
December 31, 2021 | -251.33M |
September 30, 2021 | -246.86M |
June 30, 2021 | -169.01M |
March 31, 2021 | -212.67M |
December 31, 2020 | -194.07M |
September 30, 2020 | -139.91M |
June 30, 2020 | -182.07M |
March 31, 2020 | -137.78M |
December 31, 2019 | -98.64M |
September 30, 2019 | -103.58M |
June 30, 2019 | -84.70M |
March 31, 2019 | -54.17M |
December 31, 2018 | -27.64M |
September 30, 2018 | 8.79M |
June 30, 2018 | -10.36M |
Date | Value |
---|---|
March 31, 2018 | 2.961M |
December 31, 2017 | -10.06M |
September 30, 2017 | -44.67M |
June 30, 2017 | -52.98M |
March 31, 2017 | -90.88M |
December 31, 2016 | -103.57M |
September 30, 2016 | -120.58M |
June 30, 2016 | -124.26M |
March 31, 2016 | -129.50M |
December 31, 2015 | -124.34M |
September 30, 2015 | -102.00M |
June 30, 2015 | -91.27M |
March 31, 2015 | -80.26M |
December 31, 2014 | -57.27M |
September 30, 2014 | -63.74M |
June 30, 2014 | -51.88M |
March 31, 2014 | -52.51M |
December 31, 2013 | -46.92M |
September 30, 2013 | -43.50M |
June 30, 2013 | -44.52M |
March 31, 2013 | -39.20M |
December 31, 2012 | -47.93M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-356.65M
Minimum
Dec 2022
-84.70M
Maximum
Jun 2019
-204.05M
Average
-212.67M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Sarepta Therapeutics Inc | -500.99M |
Catalyst Pharmaceuticals Inc | 143.60M |
Pfizer Inc | 8.70B |
Geron Corp | -167.74M |
Perspective Therapeutics Inc | -36.91M |